Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosis

Differentiation of Effector CD4 T Cell Populations

(2010) Jinfang Zhu et al.   Annual Review of Immunology

The inductive effect of interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes

(2010) A. ISHIZAKA et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis

(2010) Sakhina Begum-Haque et al.   JOURNAL OF NEUROIMMUNOLOGY

Long-term treatment of multiple sclerosis with glatiramer acetate: Natural history of the subtypes of anti-glatiramer acetate antibodies and their correlation with clinical efficacy

(2010) Dimitros Karussis et al.   JOURNAL OF NEUROIMMUNOLOGY

Breakthrough disease during interferon-  therapy in MS: No signs of impaired biologic response

(2010) D. Hesse et al.   NEUROLOGY

Identification of new sensitive biomarkers for thein vivoresponse to interferon-β treatment in multiple sclerosis using DNA-array evaluation

(2009) F. Sellebjerg et al.   EUROPEAN JOURNAL OF NEUROLOGY

250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

(2009) Paul O'Connor et al.   LANCET NEUROLOGY

Absence of MxA induction by interferon   in patients with MS reflects complete loss of bioactivity

(2009) D. Hesse et al.   NEUROLOGY

Efficacy of treatment of MS with IFN -1b or glatiramer acetate by monthly brain MRI in the BECOME study

(2009) D. Cadavid et al.   NEUROLOGY

The mechanism of action of glatiramer acetate treatment in multiple sclerosis

(2009) M. K. Racke et al.   NEUROLOGY

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

(2008) Daniel D Mikol et al.   LANCET NEUROLOGY

Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-β treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression

(2008) M Krakauer et al.   Multiple Sclerosis Journal

Gene expression analysis of interferon-β treatment in multiple sclerosis

(2008) F Sellebjerg et al.   Multiple Sclerosis Journal